The deal, under which Crucell will work with J&J???s Ortho-McNeil-Janssen Pharmaceuticals, also includes development milestones and royalty payments.Ortho-McNeil will have commercialization rights to resulting products worldwide except the EU and certain other European countries where Crucell will hold commercialization rights.